P R E S S R E L E A S E
LINEBERRY RESEARCH ASSOCIATES
CELEBRATES FOURTH ANNIVERSARY Company Increases Staff, Plans Expansion of Facilities
Research Triangle Park, NC (August 9, 1999) Lineberry Research Associates (LRA), a full-service contract research organization and consulting firm, celebrates its fourth anniversary this summer with the addition of several key staff members and the planned expansion of its offices.
"We are carefully growing our company to support our rapidly expanding client base," said Charles Lineberry, Ph.D., LRA President and co-founder. "At LRA, we are committed to providing our clients with the highest quality strategic counsel to help guide and support their drug development efforts."
LRA has been profitable every year since inception, and staff growth has been steady at an average annual growth rate of 40 percent. To accommodate this expansion and future growth plans, LRA will be doubling their office space to 35,000 square feet by year end. In addition, the company has hired a number of seasoned professionals with years of industry experience who will add to the companys professional, yet relaxed corporate culture.
"LRAs people are our most valued asset," said Deborah Zurek, Pharm.D., LRA Human Resources Director. "Everyone feels they have a role in the success of the business, and we pride ourselves on having a culture where people work hard together, have fun, and appreciate each others efforts."
LRA boasts experience in a broad range of therapeutic areas, with particular expertise in central nervous system, analgesia and oncology research. With more than 30 pharmaceutical companies on their client roster, LRA has long-standing relationships with major pharmaceutical companies (such as Glaxo Wellcome) as well as smaller virtual companies (such as Orphan Medical). The company is especially proud of a repeat business rate of more than 90%.
Lineberry Research Associates provides complete drug development capabilities, from IND application to NDA approval and post-marketing. In addition to managing clinical trials, the company offers pharmaceutical and biotechnology clients high level strategic and regulatory consulting services and expertise in scientific writing and medical communications.